PT - JOURNAL ARTICLE AU - Yan Zhao AU - Jin-Xian Huang TI - Correspondence on ‘Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomized, placebo-controlled, phase 3 trial’ AID - 10.1136/annrheumdis-2021-220759 DP - 2021 Jun 24 TA - Annals of the Rheumatic Diseases PG - annrheumdis-2021-220759 4099 - http://ard.bmj.com/content/early/2021/06/25/annrheumdis-2021-220759.short 4100 - http://ard.bmj.com/content/early/2021/06/25/annrheumdis-2021-220759.full